Jumo Health
Founded 2009 · 89 employees on LinkedIn · 4 known investors
Jumo Health provides patient experience solutions for clinical trials, focusing on building patient readiness through education and behavioral systems rather than traditional recruitment. The company serves clinical operations leaders and sponsors managing complex trials, offering tools to improve patient enrollment, retention, and completion rates.
Also known as Jumo Health USA, Inc. · Medikidz
Investors · 4
Also in the syndicate · 1
Company profile
researched Aug 2026Jumo Health, incorporated as Jumo Health USA, Inc., is a health technology and services company that positions itself as a "Patient Experience Organization" (PXO) for clinical trials. Operating since 2009 and based in New Haven, Connecticut, the company focuses on what it calls patient readiness: the degree to which a patient is cognitively, emotionally, practically and contextually prepared to participate in and complete a clinical trial. Its stated premise is that conventional trial infrastructure assigns ownership for eligibility, recruitment, consent, site execution and data collection, but not for whether patients are actually prepared to sustain participation, so screen failure, early withdrawal, site burden and rescue spend recur.
The company delivers two solutions that can be purchased separately or together. CORE (Content for Onboarding & Readiness Education) is a readiness education system that translates protocol complexity into practical understanding for patients, caregivers, families and sites, aligning expectations before consent and reinforcing comprehension during participation, with culturally and linguistically adapted materials. PRISM (Patient Readiness & Intelligence System) identifies eligible patients using claims, EMR, EHR, lab and genetic data plus social and behavioral determinants; assesses structural, cognitive, emotional and behavioral readiness; prioritizes patients by likely activation, persistence and completion; delivers governed conversational education and interventions; and monitors retention and completion risk across the trial lifecycle.
Historically, the company has also been described as a provider of age-appropriate, culturally sensitive medical education, producing evidence-based content on more than 200 conditions and therapeutic areas developed with key opinion leaders and advocacy groups, including books, videos and interactive tools distributed in over 90 languages to patients and caregivers in more than 75 countries.
Founding story
Founded in 2009 by Kate Hersov, per a third-party asset profile; the business was originally known as Medikidz.
Business model
Jumo Health sells patient-experience and readiness services to clinical trial sponsors and their partners, offering CORE as a standalone education system or combined with the PRISM readiness intelligence system. It states it is not a media-buying or lead-generation recruitment vendor, and positions its work to complement sponsors, CROs, sites and technology partners without adding readiness burden to sites. One source also describes the sale of educational resources such as titles on type 1 diabetes and concussions through an e-commerce site at consumer price points.
Revenue is derived from engagements with biopharma and biotech sponsors and CRO partners for readiness education and readiness-intelligence programs across studies, and, per one source, from direct sales of educational books and materials through the company's e-commerce website (for example, titles priced at $12.95-$19.95). A third-party data provider estimated annual revenue in the $50M-$100M range as of July 2026.
Traction
Company-reported figures include 100+ clients, 300+ clinical studies, 72,000+ patients supported, and 270+ conditions covered in 90+ languages, plus work with 17 of the top 25 global pharmaceutical companies by 2024 R&D spend. A third-party profile lists approximately 85 employees as of July 2026 and estimated annual revenue of $50M-$100M.
Latest developments
In February 2026 Jumo Health announced a strategic partnership with Areti Health, an AI technology company, to advance the innovation and execution of PRISM, its readiness-based clinical trial recruitment, enrollment and retention system. Brittany Erana was appointed Chief Executive Officer in 2025, following the August 2024 investment by Falfurrias Capital Partners and the appointment of Adam Cossman as board Chairman.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company reports more than 100 clients, 300+ clinical studies, 72,000+ patients and coverage of 270+ conditions in 90+ languages, and states it powers studies for 17 of the top 25 global pharmaceutical companies by 2024 R&D spend. Named clients cited by a third-party profile include Pfizer, Sanofi, GSK, AbbVie, Novartis and Jaguar Gene Therapy. It frames its category as distinct from agencies, do-it-yourself sponsor programs and CROs.
Jumo Health frames patient readiness as an owned operating discipline rather than a byproduct of recruitment activity, combining behavioral science, health literacy, human-centered design, real-world data and AI-enabled execution. It contrasts CORE with agency campaign work (measured on delivery rather than comprehension), fragmented in-house efforts, and CRO execution models that assume patients arrive prepared, and contrasts PRISM with recruitment platforms optimized for funnel volume and conversion.
Technology
The platform ingests claims, EMR, EHR, lab and genetic data alongside social and behavioral determinants to identify eligible patients and score readiness, then orchestrates governed conversational education and interventions and monitors burden accumulation, disengagement and completion risk. A third-party profile lists an AWS-based, AI-enabled and analytics-oriented stack, along with tools including Adobe Creative Cloud, SQL, Sketch, Shopify and Ruby.
Go-to-market
Jumo Health sells directly to sponsors and clinical operations teams, offering two entry points — starting with CORE education and scaling to PRISM intelligence, or deploying the full readiness system at once — and works alongside existing CRO, site and technology infrastructure. It also uses partnerships, such as with Areti Health for AI-enabled readiness and with the I Choose Life Foundation for health equity–focused recruitment and retention.
Biopharma and biotech sponsors, clinical development and clinical operations teams, patient experience leaders, and CRO partners; the systems are also used by sites, patients, caregivers and families participating in trials.
Geography
Headquartered in New Haven, Connecticut, US, with employees across North America, Europe and Asia per a third-party profile. Educational materials are described as reaching patients and caregivers in more than 75 countries and in over 90 languages.
History
The company was established in 2009, originally known as Medikidz, and later operated as Jumo Health, a provider of age-appropriate, culturally sensitive medical education and clinical trial patient resources. Leadership additions include Raymond N. Altieri as Executive Vice President and Chief Financial Officer (2020), Snev Dorsonne as Chief Operating Officer (2024), Adam Cossman as board Chairman (2024), and Brittany Erana as Chief Executive Officer (2025). In February 2023 it expanded a health equity service line focused on recruitment and retention of people of color in clinical trials with the I Choose Life Foundation. In August 2024, Falfurrias Capital Partners invested in the company, with stated plans to broaden core capabilities and patient engagement. In February 2026 it announced a strategic partnership with Areti Health to advance PRISM. More recently the company has repositioned itself as a Patient Experience Organization built around patient readiness.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 7
launches, deals, and filingsJumo Health announced a strategic partnership with Areti Health (AretiHealth Labs LLC), an AI technology company, to advance the innovation and execution of PRISM, its readiness-based clinical trial recruitment, enrollment and retention system.
Jumo Health announced the appointment of Brittany Erana as Chief Executive Officer; announcement dated June 2, 2025 from New Haven, Conn.
Adam Cossman, an executive advisor on the Falfurrias team with 25 years of pharmaceutical commercialization experience, joined Jumo Health's board of directors as Chairman.
Falfurrias Capital Partners invested in Jumo Health USA, Inc.; the company planned to use the funding to broaden its core capabilities and patient engagement.
Jumo Health and the I Choose Life Foundation expanded the company's health equity service line to include recruitment and retention of people of color in clinical trials.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 5
primary sources listed
- Jumo Healthjumohealth.com · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Jumo Health do?
- Jumo Health is a Patient Experience Organization that makes patient readiness operational across clinical trial enrollment and completion.
- Who are Jumo Health's investors?
- Jumo Health's investors include Excelerate Health Ventures, Falfurrias, Hatteras Venture Partners.